Rohith Palli

Rohith Palli

Auto-generated profile, based on publicly available information

Rohith Palli

University of Washington Department of Biomedical Informatics and Medical Education, IT Services, and Division of General Internal Medicine. Box 358047. 850 Republican St. Seattle, WA 98195

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
RPRohith Palli
Rohith Palli
MPMukta G Palshikar
Mukta G Palshikar
JTJuilee Thakar
Juilee Thakar
Pathway analysis is widely used to gain mechanistic insights from high-throughput omics data. However, most existing methods do not consider signal integration represented by pathway topology, resulting in enrichment of convergent pathways when downstream genes are modulated. Incorporation of signal flow and integration in pathway analysis could rank the pathways based on modulation in key regulatory genes. This implementation can be facilitated for large-scale data by discrete state network modeling due to simplicity in parameterization. Here, we model cellular heterogeneity using discrete state dynamics and measure pathway activities in cross-sectional data. We introduce a new algorithm, Boolean Omics Network Invariant-Time Analysis (BONITA), for signal propagation, signal integration, and pathway analysis. Our signal propagation approach models heterogeneity in transcriptomic data as arising from intercellular heterogeneity rather than intracellular stochasticity, and propagates binary signals repeatedly across networks. Logic rules defining signal integration are inferred by genetic algorithm and are refined by local search. The rules determine the impact of each node in a pathway, which is used to score the probability of the pathway’s modulation by chance. We have comprehensively tested BONITA for application to transcriptomics data from translational studies. Comparison with state-of-the-art pathway analysis methods shows that BONITA has higher sensitivity at lower levels source node modulation and similar sensitivity at higher levels of source node modulation. Application of BONITA pathway analysis to previously validated RNA-sequencing studies identifies additional relevant pathways in in-vitro human cell line experiments and in-vivo infant studies. Additionally, BONITA successfully detected modulation of disease specific pathways when comparing relevant RNA-sequencing data with healthy controls. Most interestingly, the two highest impact score nodes identified by BONITA included known drug targets. Thus, BONITA is a powerful approach to prioritize not only pathways but also specific mechanistic role of genes compared to existing methods. BONITA is available at: https://github.com/thakar-lab/BONITA. 21st-century biotechnology has enabled measurements of genes and proteins at large scale by RNA sequencing and proteomics technologies. In particular, RNA-sequencing has become a first step of unbiased interrogation. These studies frequently produce a long list of differentially abundant genes, which become interpretable by widely used pathway analysis methods. The pathway topologies frequently include information on how genes interact and influence each other’s expression, but current methods do not utilize this information to estimate signal flow through each pathway. We have developed a model of binary (on/off) behavior that accounts for varying expression across samples as different proportions of cells expressing genes. We model signal flow by averaging repeated simulations of individual cells passing binary signals through molecular networks. We use this model to infer regulatory rules explaining gene expression. These rules of signal integration for all nodes in the network are used to identify the most important genes, and to determine if a pathway’s activity is different between two groups. BONITA compares favorably to previous approaches using simulated and real data. Furthermore, application to 36 datasets from 15 different diseases demonstrates BONITA’s exceptional ability to detect drug targets.

15 June 2012 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
AMArtem B. Mamonov
Artem B. Mamonov
SLSteven Lettieri
Steven Lettieri
YDYing Ding
Ying Ding
JSJessica L. Sarver
Jessica L. Sarver
RPRohith Palli
Rohith Palli
DZDaniel M. Zuckerman
Daniel M. Zuckerman

21 September 2022 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
MPMukta G. Palshikar
Mukta G. Palshikar
RPRohith Palli
Rohith Palli
ATAlicia Tyrell
Alicia Tyrell
SMSanjay Maggirwar
Sanjay Maggirwar
GSGiovanni Schifitto
Giovanni Schifitto
JTJuilee Thakar
Juilee Thakar
Atherosclerosis (AS)-associated cardiovascular disease is an important cause of mortality in an aging population of people living with HIV (PLWH). This elevated risk has been attributed to viral infection, anti-retroviral therapy, chronic inflammation, and lifestyle factors. However, the rates at which PLWH develop AS vary even after controlling for length of infection, treatment duration, and for lifestyle factors. To investigate the molecular signaling underlying this variation, we sequenced 9368 peripheral blood mononuclear cells (PBMCs) from eight PLWH, four of whom have atherosclerosis (AS+). Additionally, a publicly available dataset of PBMCs from persons before and after HIV infection was used to investigate the effect of acute HIV infection. To characterize dysregulation of pathways rather than just measuring enrichment, we developed the single-cell Boolean Omics Network Invariant Time Analysis (scBONITA) algorithm. scBONITA infers executable dynamic pathway models and performs a perturbation analysis to identify high impact genes. These dynamic models are used for pathway analysis and to map sequenced cells to characteristic signaling states (attractor analysis). scBONITA revealed that lipid signaling regulates cell migration into the vascular endothelium in AS+ PLWH. Pathways implicated included AGE-RAGE and PI3K-AKT signaling in CD8+ T cells, and glucagon and cAMP signaling pathways in monocytes. Attractor analysis with scBONITA facilitated the pathway-based characterization of cellular states in CD8+ T cells and monocytes. In this manner, we identify critical cell-type specific molecular mechanisms underlying HIV-associated atherosclerosis using a novel computational method.

23 April 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJustin Spiriti
Justin Spiriti
SSSundar Raman Subramanian
Sundar Raman Subramanian
RPRohith Palli
Rohith Palli
MWMaria Wu
Maria Wu
DZDaniel M Zuckerman
Daniel M Zuckerman
There is a vast gulf between the two primary strategies for simulating protein-ligand interactions. Docking methods significantly limit or eliminate protein flexibility to gain great speed at the price of uncontrolled inaccuracy, whereas fully flexible atomistic molecular dynamics simulations are expensive and often suffer from limited sampling. We have developed a flexible docking approach geared especially for highly flexible or poorly resolved targets based on mixed-resolution Monte Carlo (MRMC), which is intended to offer a balance among speed, protein flexibility, and sampling power. The binding region of the protein is treated with a standard atomistic force field, while the remainder of the protein is modeled at the residue level with a Gō model that permits protein flexibility while saving computational cost. Implicit solvation is used. Here we assess three facets of the MRMC approach with implications for other docking studies: (i) the role of receptor flexibility in cross-docking pose prediction; (ii) the use of non-equilibrium candidate Monte Carlo (NCMC) and (iii) the use of pose-clustering in scoring. We examine 61 co-crystallized ligands of estrogen receptor α, an important cancer target known for its flexibility. We also compare the performance of the MRMC approach with Autodock smina. Adding protein flexibility, not surprisingly, leads to significantly lower total energies and stronger interactions between protein and ligand, but notably we document the important role of backbone flexibility in the improvement. The improved backbone flexibility also leads to improved performance relative to smina. Somewhat unexpectedly, our implementation of NCMC leads to only modestly improved sampling of ligand poses. Overall, the addition of protein flexibility improves the performance of docking, as measured by energy-ranked poses, but we do not find significant improvements based on cluster information or the use of NCMC. We discuss possible improvements for the model including alternative coarse-grained force fields, improvements to the treatment of solvation, and adding additional types of NCMC moves.

7 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MPMukta G. Palshikar
Mukta G. Palshikar
RPRohith Palli
Rohith Palli
ATAlicia Tyrell
Alicia Tyrell
SMSanjay Maggirwar
Sanjay Maggirwar
GSGiovanni Schifitto
Giovanni Schifitto
JTJuilee Thakar
Juilee Thakar
Background Atherosclerosis (AS)-associated cardiovascular disease is an important cause of mortality in an aging population of people living with HIV (PLWH). This elevated risk of atherosclerosis has been attributed to viral infection, prolonged usage of anti-retroviral therapy, and subsequent chronic inflammation. Methods To investigate dysregulated immune signaling in PLWH with and without AS, we sequenced 9368 peripheral blood mononuclear cells (PBMCs) from 8 PLWH, 4 of whom also had atherosclerosis (AS+). To develop executable models of signaling pathways that drive cellular states in HIV-associated atherosclerosis, we developed the single-cell Boolean Omics Network Invariant Time Analysis (scBONITA) algorithm. ScBONITA (a) uses single-cell RNA sequencing data to infer Boolean rules for topologically characterized networks, (b) prioritizes genes based on their impact on signaling, (c) performs pathway analysis, and (d) maps sequenced cells to characteristic signaling states. We used scBONITA to identify dysregulated pathways in different cell-types from AS+ PLWH and AS-PLWH. To compare our findings with pathways associated with HIV infection, we used scBONITA to analyze a publicly available dataset of PBMCs from subjects before and after HIV infection. Additionally, the executable Boolean models characterized by scBONITA were used to analyze observed cellular states corresponding to the steady states of signaling pathways Results We identified an increased subpopulation of CD8+ T cells and a decreased subpopulation of monocytes in AS+ PLWH. Dynamic modeling of signaling pathways and pathway analysis with scBONITA provided a new perspective on the mechanisms of HIV-associated atherosclerosis. Lipid metabolism and cell migration pathways are induced by AS rather than by HIV infection. These pathways included AGE-RAGE and PI3K-AKT signaling in CD8+ T cells, and glucagon and cAMP signaling pathways in monocytes. Further analysis of other cell subpopulations suggests that the highly interconnected PI3K-AKT signaling pathway drives cell migratory state in response to dyslipidemia. scBONITA attractor analysis mapped cells to pathway-specific signaling states that correspond to distinct cellular states. Conclusions Dynamic network modeling and pathway analysis with scBONITA indicates that dysregulated lipid signaling regulates cell migration into the vascular endothelium in AS+ PLWH. Attractor analysis with scBONITA facilitated pathway-based characterization of cellular states that are not apparent in gene expression analyses.

3 October 2012 in Pediatric Research
Verified
Journal Article
Closed access
NLNaomi R. Latorraca
Naomi R. Latorraca
RPRohith Palli
Rohith Palli